Warning: substr() expects parameter 1 to be string, object given in D:\websites\www.medrio.com\partners\wp-content\themes\ward\archive.php on line 18

Tag Archive for FDA


The Future Looks Bright for mHealth in Clinical Trials

mHealth technology – the practice of collecting and managing medical data using phones, tablets and other mobile devices – seems poised to flood the clinical research industry like never before: Pharma companies, CROs and academics all recognize the potential of these technologies to improve clinical trials, and regulators are signaling their approval by taking action on new guidelines for their…

Monthly News Roundup - Wordpress

Monthly News Roundup: January 2017

Welcome to the Medrio Monthly News Roundup, in which we brief you on a sample of events and developments taking place around the industry. This recurring update functions on popular demand – the stories in this post come from the articles in our social media feeds that garnered the most attention from our readers and followers. Your likes, clicks, and…


Adapting to New Tech in Clinical Trials

The use of new tech in clinical trials is mutually beneficial to both the clinical research and technology industries. It enables the former to make great strides in areas such as efficiency and patient engagement, while tech developers gain access to a large and growing new market. But it also brings challenges. Clinical trials are conducted according to standard operating…


Transparency vs. Confidentiality

With several exceptions, the FDA requires that studies of drugs and devices be registered, and their results reported, by their sponsors or principal investigators1. But there is often a tug-of-war, in the clinical research field, between researchers who value confidentiality in trial results and governments and advocacy groups who demand transparency2. The issue is complex, with various interests coming into…